tiprankstipranks
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX

CytomX Therapeutics (CTMX) Financial Statements

478 Followers

CytomX Therapeutics Financial Overview

CytomX Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.017; its P/E ratio is -124.12; CytomX Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 26.61M$ 26.38M$ 24.72M$ 23.50M$ 947.00K
Gross Profit$ 26.61M$ 26.38M$ 24.72M$ 23.50M$ 947.00K
EBIT$ 1.91M$ 5.82M$ -1.09M$ -3.31M$ -28.68M
EBITDA$ 166.00K$ 4.37M$ -2.20M$ -4.25M$ -28.08M
Net Income Common Stockholders$ 837.00K$ 2.99M$ -1.09M$ -3.31M$ -27.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 174.51M$ 194.11M$ 180.86M$ 204.50M$ 193.65M
Total Assets$ 201.79M$ 221.17M$ 209.19M$ 234.63M$ 260.89M
Total Debt$ 13.97M$ 10.60M$ 11.75M$ 12.87M$ 13.97M
Net Debt$ -160.53M$ -183.51M$ -169.11M$ -191.63M$ -179.68M
Total Liabilities$ 249.24M$ 272.40M$ 294.21M$ 321.27M$ 346.64M
Stockholders Equity$ -47.45M$ -51.24M$ -85.03M$ -86.64M$ -85.75M
Cash Flow-
Free Cash Flow$ -22.23M$ -18.25M$ -25.70M$ 9.30M$ -1.58M
Operating Cash Flow$ -21.96M$ -18.24M$ -25.18M$ 9.35M$ -1.39M
Investing Cash Flow$ 12.87M$ -42.94M$ 26.04M$ -146.64M$ 99.82M
Financing Cash Flow$ 244.00K$ 29.67M$ 317.00K-$ 190.00K
Currency in USD

CytomX Therapeutics Earnings and Revenue History

CytomX Therapeutics Debt to Assets

CytomX Therapeutics Cash Flow

CytomX Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis